Document is current
Any future updates will be listed below
-
Authors
Keegan, Joshua
Sorbello, Sydney
Mori, Joakin
Muratani, Shugo
Leshchiner, Ignaty
Heaphy, Christopher M.
Flynn, Rachel L.
-
Funding
Funding for this research was provided by:
American Cancer Society (DBG-23-1148324)
US Department of Defense Rare Cancer Research Program (HT9425-23-1-0819)
US Department of Defense Rare Cancer Research Program (HT9425-23-1-0819)
National Institutes of Health (1UL1TR001430)
- License Information
-
More Information
Article History
Received: 29 January 2026
Accepted: 21 May 2026
First Online: 4 June 2026
Declarations
:
: Declared exempt from human subjects research by Boston University Medical Campus Institutional Review Board (IRB).
: Not Applicable.
: The authors declare no competing interests.
